Early Treatment with Hepatocyte Growth Factor Improves Cardiac Function in Experimental Heart Failure Induced by Myocardial Infarction

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2003-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1124/jpet.102.041772PMID 12538818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition.

  2002cited by this paper
• Effects of Early Angiotensin-Converting Enzyme Inhibition on Cardiac Gene Expression After Acute Myocardial Infarction

  2001cited by this paper
• A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats.

  2001influential reference
• Continuous intravenous infusion of deleted form of hepatocyte growth factor attenuates hepatic ischemia-reperfusion injury in rats.

  2001cited by this paper
• Serial Changes in Serum VEGF and HGF in Patients with Acute Myocardial Infarction

  2000cited by this paper
• Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets

  2000cited by this paper
• Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters.

  2000cited by this paper
• Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease

  2000cited by this paper
• Recombinant human hepatocyte growth factor protects the liver against hepatic ischemia and reperfusion injury in rats.

  2000cited by this paper
• Production of hepatocyte growth factor during acute myocardial infarction

  2000cited by this paper
• Hepatocyte growth factor plasma levels after myocardial infarction are not affected by recombinant tissue-type plasminogen-activator therapy.

  2000cited by this paper
• Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.

  2000cited by this paper
• Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function.

  2000cited by this paper
• Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro.

  1999cited by this paper
• Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart.

  1999cited by this paper
• Angiotensin-converting enzyme inhibition restores hepatocyte growth factor production in patients with congestive heart failure.

  1999influential reference
• Hepatocyte growth factor and the kidney: it is not just for the liver.

  1999cited by this paper
• Hepatocyte growth factor: Mesenchymal signal for epithelial homeostasis

  1998cited by this paper
• Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection.

  1998cited by this paper
• Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model.

  1997cited by this paper
• Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration.

  1997cited by this paper
• Apoptosis in the heart.

  1997cited by this paper
• Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction.

  1996cited by this paper
• Programmed myocyte cell death affects the viable myocardium after infarction in rats.

  1996cited by this paper
• Apoptosis in the heart.

  1996cited by this paper
• Apoptosis in ischemic and reperfused rat myocardium.

  1996cited by this paper
• Emerging multipotent aspects of hepatocyte growth factor.

  1996cited by this paper
• Growth hormone improves cardiac performance in experimental heart failure.

  1995cited by this paper
• Induction of liver growth in normal mice by infusion of hepatocyte growth factor/scatter factor.

  1995influential reference
• Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats.

  1995influential reference
• The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis

  1995cited by this paper
• Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.

  1993cited by this paper
• Scatter factor induces blood vessel formation in vivo.

  1993cited by this paper
• Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats

  1993cited by this paper
• Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

  1992cited by this paper
• Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.

  1991cited by this paper
• Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.

  1991cited by this paper
• Molecular cloning and expression of human hepatocyte growth factor

  1989cited by this paper
• Myocardial Infarct Size and Ventricular Function in Rats

  1979cited by this paper

• Temporal Exercise Conditioning Confers Dual-Phase Cardioprotection Against Isoproterenol-Induced Injury in a Rat Model.

  2026cites this paper
• The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction

  2025cites this paper
• Hepatocyte growth factor and risk of incident stroke in Black and White Americans in the Reasons for Geographic and Racial Differences in Stroke study

  2024cites this paper
• The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker

  2021cites this paper
• Prognostic relevance of longitudinal HGF levels in serum of patients with ovarian cancer

  2021cites this paper
• Effect of Co-culturing Fibroblasts in Human Skeletal Muscle Cell Sheet on Angiogenic Cytokine Balance and Angiogenesis

  2020cites this paper
• Hepatocyte growth factor plays a particular role in progression of overall cardiac damage in experimental pulmonary hypertension

  2019cites this paper
• Sustained Functional Improvement by Hepatocyte Growth Factor-Like Small Molecule BB3 after Focal Cerebral Ischemia in Rats and Mice

  2015cites this paper
• Conséquences de l'hypoxie sur la régulation de la signalisation HGF/SF-MET

  2015cites this paper
• Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction.

  2015cites this paper
• Effets des clivages du récepteur tyrosine kinase Met par les calpaïnes sur la motilité et la mort cellulaire

  2014cites this paper
• HGF–Met Pathway in Regeneration and Drug Discovery

  2014cites this paper
• Hepatocyte Growth Factor: Cardiotrophic Roles and Potential Therapeutics for Cardiovascular Diseases

  2014cites this paper
• Author ' s personal copy Cardiomyocyte-speci fi c overexpression of human stem cell factor protects against myocardial ischemia and reperfusion injury ☆

  2013cites this paper
• Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma

  2013cites this paper
• Cardiomyocyte-specific overexpression of human stem cell factor protects against myocardial ischemia and reperfusion injury.

  2013cites this paper
• Intramyocardial transfer of hepatocyte growth factor as an adjunct to CABG: phase I clinical study

  2012cites this paper
• Pro-Angiogenic Cytokines as Cardiovascular Therapeutics

  2012cites this paper
• Effect of hepatocyte growth factor and angiotensin II on rat cardiomyocyte hypertrophy

  2012cites this paper
• Prevention and recovery of hibernating myocardium by microvascular repair.

  2011cites this paper
• Hepatocyte growth factor incorporated into herpes simplex virus vector accelerates facial nerve regeneration after crush injury

  2011cites this paper
• Emerging technologies for enabling proangiogenic therapy

  2011cites this paper
• Umbilical Cord‐Derived Mesenchymal Stem Cells With Forced Expression of Hepatocyte Growth Factor Enhance Remyelination and Functional Recovery in a Rat Intracerebral Hemorrhage Model

  2010cites this paper
• Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis

  2010cites this paper
• Pro-angiogenic cytokines as cardiovascular therapeutics: assessing the potential.

  2008cites this paper
• Activation of Notch-Mediated Protective Signaling in the Myocardium

  2008cites this paper
• Science to Practice : Can MR Imaging Be Used to Determine the Efficacy of Gene Therapy in the Heart ?

  2008cites this paper
• Therapeutic angiogenesis using naked DNA expressing two isoforms of the hepatocyte growth factor in a porcine acute myocardial infarction model.

  2008cites this paper
• Novel Therapeutic Strategy for Stroke in Rats by Bone Marrow Stromal Cells and ex vivo HGF Gene Transfer with HSV-1 Vector

  2006cites this paper
• c-Met Ectodomain Shedding Rate Correlates with Malignant Potential

  2006cites this paper
• Targeting genes and cells in the progression to heart failure.

  2005cites this paper
• Experimental Cell Transplantation for Myocardial Repair

  2005cites this paper
• Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ Stem Cells, and Mononuclear Cells Expressing Early Cardiac, Muscle, and Endothelial Markers Into Peripheral Blood in Patients With Acute Myocardial Infarction

  2004cites this paper
• Hereditary papillary renal carcinoma type I.

  2004cites this paper
• Mobilization of CD 34 / CXCR 4 , CD 34 / CD 117 , c-met Stem Cells , and Mononuclear Cells Expressing Early Cardiac , Muscle , and Endothelial Markers Into Peripheral Blood in Patients With Acute Myocardial Infarction

  2004cites this paper
• The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure.

  2004cites this paper
• Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.

  2004cites this paper
• Met provides essential signals for liver regeneration.

  2004cites this paper
• Angiogenic growth factors and hypertension

  2004cites this paper
• Met, metastasis, motility and more

  2003cites this paper